Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial
印度即时生产型抗CD19 CAR-T细胞疗法的安全性、有效性和总成本:VELCART试验
期刊:Molecular Therapy Oncology
影响因子:5.3
doi:10.1016/j.omton.2025.200977
Palani, Hamenth Kumar; Arunachalam, Arun Kumar; Kulkarni, Uday; Yasar, Mohammed; Venkatraman, Arvind; Palanikumar, Swathy; Radhakrishnan, Reeshma Nair; Solomon, Majeela; Rajasekaran, Abirami; Bankar, Aniket; Datari, Phaneendra Venkateswara Rao; Selvarajan, Sushil; Korula, Anu; Dash, Pradyot; Schneider, Dina; Wirthlin, Louisa; Abraham, Aby; George, Biju; Mathews, Vikram